97 related articles for article (PubMed ID: 15967873)
1. Functional complementation and the analysis of opioid receptor homodimerization.
Pascal G; Milligan G
Mol Pharmacol; 2005 Sep; 68(3):905-15. PubMed ID: 15967873
[TBL] [Abstract][Full Text] [Related]
2. Mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Pharmacol Exp Ther; 2006 Aug; 318(2):683-90. PubMed ID: 16690720
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
Wise A; Sheehan M; Rees S; Lee M; Milligan G
Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
[TBL] [Abstract][Full Text] [Related]
4. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions between the alpha1b-adrenoceptor and Galpha11 are compromised by de-palmitoylation of the G protein but not of the receptor.
Novotny J; Durchankova D; Ward RJ; Carrillo JJ; Svoboda P; Milligan G
Cell Signal; 2006 Aug; 18(8):1244-51. PubMed ID: 16297597
[TBL] [Abstract][Full Text] [Related]
6. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
7. Expression of the third intracellular loop of the delta-opioid receptor inhibits signaling by opioid receptors and other G protein-coupled receptors.
Morou E; Georgoussi Z
J Pharmacol Exp Ther; 2005 Dec; 315(3):1368-79. PubMed ID: 16160084
[TBL] [Abstract][Full Text] [Related]
8. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution reveals additional roles for N- and C-terminal domains of g(alpha) in muscarinic receptor coupling.
Slessareva JE; Graber SG
Biochemistry; 2003 Jun; 42(24):7552-60. PubMed ID: 12809511
[TBL] [Abstract][Full Text] [Related]
10. Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp.
Huang P; Li J; Chen C; Visiers I; Weinstein H; Liu-Chen LY
Biochemistry; 2001 Nov; 40(45):13501-9. PubMed ID: 11695897
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
Lester PA; Traynor JR
Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
[TBL] [Abstract][Full Text] [Related]
12. Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G-proteins or altered endocytosis profiles.
Zhang YQ; Limbird LE
Biochem Soc Trans; 2004 Nov; 32(Pt 5):856-60. PubMed ID: 15494033
[TBL] [Abstract][Full Text] [Related]
13. Engineering and functional immobilization of opioid receptors.
Ott D; Neldner Y; Cèbe R; Dodevski I; Plückthun A
Protein Eng Des Sel; 2005 Mar; 18(3):153-60. PubMed ID: 15790572
[TBL] [Abstract][Full Text] [Related]
14. Chimeric G proteins allow a high-throughput signaling assay of Gi-coupled receptors.
Coward P; Chan SD; Wada HG; Humphries GM; Conklin BR
Anal Biochem; 1999 Jun; 270(2):242-8. PubMed ID: 10334841
[TBL] [Abstract][Full Text] [Related]
15. High-affinity interactions between human alpha1A-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha1L-adrenoceptor.
Ramsay D; Carr IC; Pediani J; Lopez-Gimenez JF; Thurlow R; Fidock M; Milligan G
Mol Pharmacol; 2004 Aug; 66(2):228-39. PubMed ID: 15266013
[TBL] [Abstract][Full Text] [Related]
16. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
[TBL] [Abstract][Full Text] [Related]
17. Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptor.
Xu H; Wang X; Zimmerman D; Boja ES; Wang J; Bilsky EJ; Rothman RB
J Pharmacol Exp Ther; 2005 Oct; 315(1):248-55. PubMed ID: 15987828
[TBL] [Abstract][Full Text] [Related]
18. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms.
Snook LA; Milligan G; Kieffer BL; Massotte D
J Neurochem; 2008 May; 105(3):865-73. PubMed ID: 18182056
[TBL] [Abstract][Full Text] [Related]
20. delta-Opioid receptors exhibit high efficiency when activating trimeric G proteins in membrane domains.
Bourova L; Kostrnova A; Hejnova L; Moravcova Z; Moon HE; Novotny J; Milligan G; Svoboda P
J Neurochem; 2003 Apr; 85(1):34-49. PubMed ID: 12641725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
